ERYP
ERYTECH Pharma S.A.

1,408
Loading...
Loading...
PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
68

Frequently Asked Questions

What is Market Cap of PHAXIAM Therapeutics S.A. - ADR?
What is the 52-week high for PHAXIAM Therapeutics S.A. - ADR?
What is the 52-week low for PHAXIAM Therapeutics S.A. - ADR?
What is PHAXIAM Therapeutics S.A. - ADR stock price today?
What was PHAXIAM Therapeutics S.A. - ADR stock price yesterday?
What is the PE ratio of PHAXIAM Therapeutics S.A. - ADR?
What is the Price-to-Book ratio of PHAXIAM Therapeutics S.A. - ADR?
What is PHAXIAM Therapeutics S.A. - ADR's EBITDA?
What is the 50-day moving average of PHAXIAM Therapeutics S.A. - ADR?
How many employess does PHAXIAM Therapeutics S.A. - ADR has?

Latest ERYP News

View
No ERYP news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.